| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |